Recent Study Offers New Hope: PD-L1 Expression in Malignant Peritoneal Mesothelioma

Testing for PD-L1 expression in malignant peritoneal mesothelioma may offer insight into whether patients of this rare cancer are candidates for immunotherapy, such as checkpoint inhibition. Immunotherapy has proven beneficial in other types of mesothelioma. A new study examines it as a possible treatment for peritoneal mesothelioma patients as well. What Is PD-L1…

Read More

Women’s History Month: Notable Women in the Mesothelioma World

Women’s History Month was established in 1987 to celebrate and commemorate the contributions and accomplishments of women in history. Remembering the struggles, the sacrifices, and the victories of women in the mesothelioma community is an important part of moving treatment and activism forward. Although mesothelioma is rare in women, they make up an important part…

Read More